Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
SPRC SciSparc and NeuroThera/ClearMind collaboration advances mdma-N-acylethanolamines intellectual property for the treatment of PTSD, amid rising U.S. federal support for psychedelic innovation.
SPRC, via SciSparc and NeuroThera-Clearmind collaboration, advances intellectual property for MDMA-N-acylethanolamines aimed at treating PTSD.